March 18, 2005 - The battle against wrinkles is moving from the operating room to the office as many men and women are forgoing facelifts in favor of injectable wrinkle fillers like Botox, according to a new report on plastic surgery trends.
The American Society of Plastic Surgeons (ASPS) report shows the number of surgical cosmetic procedures has dropped by 8% from 2000 to 2004, while the number of nonsurgical cosmetic procedures has risen by 36% during the same time period.
Researchers say those figures show that reality TV shows are creating a greater awareness of cosmetic procedures, but they are not necessarily creating a stampede to the plastic surgeon's office.
"These statistics show a strong, continued, and healthy increase in cosmetic surgery that mirrors the 4.4 percent economic growth of the United States," says ASPS president Scott Spear, MD, in a news release. "However, there is no evidence in the statistics to support that TV programs have led to a dramatic surge in the amount of cosmetic surgery procedures."
In contrast, a report released last month by the American Society for Aesthetic and Plastic Surgery credited increased media coverage for a recent surge in surgical and nonsurgical cosmetic procedures performed in 2004.
But both organizations say the biggest growth has been in nonsurgical cosmetic procedures, which they attribute largely to new injectable wrinkle fillers like Botox, Restylane, and Hylaform.
Overall, the report shows there's been a 24% increase in the number of cosmetic plastic surgery and nonsurgical procedures over the last four years.
The top five surgical procedures in 2004 were:
- Liposuction (325,000 procedures)
- Nose reshaping (305,000)
- Breast augmentation (264,000)
- Eyelid surgery (233,000)
- Facelift (114,000)
Among the 7.5 million minimally invasive or nonsurgical cosmetic procedures, the top five were:
- Botox (3 million)
- Chemical peel (1.1 million)
- Microdermabrasion (859,000)
- Laser hair removal (574,000)
- Sclerotherapy (a procedure to treat varicose veins, 545,000)
Researchers say the demand for Restylane and Hylaform jumped 927% in 2004. Restylane was approved by the FDA for use in December 2003, and Hylaform was approved in April 2004.
The report shows use of the first FDA-approved wrinkle eraser, Botox, increased by 4% in 2004 and has increased by a whopping 280% since 2000.